|
|
|
Volumn 43, Issue , 1998, Pages 533-562
|
|
Use of calcium channel blockers in hypertension.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
BENZIMIDAZOLE DERIVATIVE;
CALCIUM CHANNEL BLOCKING AGENT;
DIHYDROPYRIDINE DERIVATIVE;
DILTIAZEM;
MIBEFRADIL;
NIFEDIPINE;
TETRALIN DERIVATIVE;
VASODILATOR AGENT;
VERAPAMIL;
BLOOD PRESSURE;
CASE CONTROL STUDY;
CLASSIFICATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG EFFECT;
HEART DISEASE;
HUMAN;
HYPERTENSION;
LONGITUDINAL STUDY;
PUBLIC HEALTH;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK FACTOR;
ANTIHYPERTENSIVE AGENTS;
BENZIMIDAZOLES;
BLOOD PRESSURE;
CALCIUM CHANNEL BLOCKERS;
CASE-CONTROL STUDIES;
CLINICAL TRIALS;
DIHYDROPYRIDINES;
DILTIAZEM;
HEART DISEASES;
HUMANS;
HYPERTENSION;
LONGITUDINAL STUDIES;
MIBEFRADIL;
NIFEDIPINE;
PUBLIC HEALTH;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
TETRAHYDRONAPHTHALENES;
VASODILATOR AGENTS;
VERAPAMIL;
|
|
EID: 0031603035
PISSN: 00652822
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (26)
|
|
References (102)
|
